PubHawk
Sleep Med Rev October 2021 PMID 33582532

MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review.

Lucía Pinilla, Ferran Barbé, David de Gonzalo-Calvo

Full text PDF Download social card

Mentions

3
Peak: 1 in Feb 2021
across 2 sources since Feb 2021

Extended reach

808
potential audience

Total likes

1

Video views

339

Mentions per month

Feb 2021 – Aug 2025

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The overall tone conveys acknowledgment of the review's significance, with posts like 'MicroRNAs to guide medical decision-making' and mentions of the potential to enhance diagnosis and treatment. Words such as 'important,' 'promising,' and 'must consider' suggest an appreciation but not a highly detailed or critical engagement with the research.

AgreementModerate agreement

Most discussions acknowledge the importance of the review and express support for its findings, indicating moderate agreement with the article's emphasis on microRNAs in OSA management.

InterestModerate interest

Posts show a basic level of curiosity about the topic, with some mentioning the potential for personalized medicine but lacking deep exploration.

EngagementModerate engagement

Comments include references to the article's content but do not delve into detailed analysis, reflecting moderate engagement.

ImpactModerate impact

Participants recognize the review as a potentially impactful development in diagnosing and treating sleep apnea, though without indicating a profound immediate influence.

Abstract in brief

  • Obstructive sleep apnea (OSA) is a common yet often underdiagnosed sleep disorder linked to serious health issues and increased mortality risk, making it a significant public health concern with rising prevalence worldwide.
  • The review explores the potential of microRNAs (miRNAs), small noncoding RNA molecules, as biomarkers that could improve diagnosis and treatment decisions for both children and adults with OSA, highlighting their promising role in personalized medicine.
  • It also discusses current research limitations, methodological challenges, and future steps needed to effectively integrate miRNAs into everyday clinical practice for better management of OSA.]
Read the full abstract

Top posts

Most liked on X and Bluesky
PsychiatryAI.com
@PsychiatryAIcom · X

MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review https://t.co/YpSvSDmicm

Feb 12, 2021 · 435 followers View post →
Lucía
@LuciaP_96 · X

RT @transcriptomes: MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review. https://t.co/aoMs7Y7Uml

Jun 15, 2021 · 1 share · 32 followers View post →

All mentions

Lucía
@LuciaP_96 · X

RT @transcriptomes: MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review. https://t.co/aoMs7Y7Uml

Jun 15, 2021 · 1 share · 32 followers View post →
PsychiatryAI.com
@PsychiatryAIcom · X

MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review https://t.co/YpSvSDmicm

Feb 12, 2021 · 435 followers View post →